nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—Pulmonary congestion—Delavirdine—acquired immunodeficiency syndrome	0.0133	0.0351	CcSEcCtD
Glycine—ALAS1—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.013	0.0834	CbGpPWpGaD
Glycine—Toxicity to various agents—Saquinavir—acquired immunodeficiency syndrome	0.0125	0.033	CcSEcCtD
Glycine—Respiratory tract congestion—Delavirdine—acquired immunodeficiency syndrome	0.011	0.029	CcSEcCtD
Glycine—GLDC—blood plasma—acquired immunodeficiency syndrome	0.00942	0.0203	CbGeAlD
Glycine—GARS—nerve—acquired immunodeficiency syndrome	0.00901	0.0194	CbGeAlD
Glycine—Electrolyte imbalance—Ritonavir—acquired immunodeficiency syndrome	0.00891	0.0235	CcSEcCtD
Glycine—GRIN2C—nerve—acquired immunodeficiency syndrome	0.00886	0.0191	CbGeAlD
Glycine—Acidosis—Zidovudine—acquired immunodeficiency syndrome	0.00864	0.0228	CcSEcCtD
Glycine—Lung disorder—Stavudine—acquired immunodeficiency syndrome	0.00778	0.0205	CcSEcCtD
Glycine—SLC6A5—spinal cord—acquired immunodeficiency syndrome	0.0065	0.014	CbGeAlD
Glycine—Acidosis—Lamivudine—acquired immunodeficiency syndrome	0.00617	0.0163	CcSEcCtD
Glycine—GRIN2A—nerve—acquired immunodeficiency syndrome	0.00612	0.0132	CbGeAlD
Glycine—GPR18—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00599	0.0385	CbGpPWpGaD
Glycine—SHMT2—blood plasma—acquired immunodeficiency syndrome	0.00593	0.0127	CbGeAlD
Glycine—GLYATL1—lung—acquired immunodeficiency syndrome	0.00591	0.0127	CbGeAlD
Glycine—BAAT—Recycling of bile acids and salts—ALB—acquired immunodeficiency syndrome	0.00589	0.0379	CbGpPWpGaD
Glycine—GLYATL2—blood—acquired immunodeficiency syndrome	0.00573	0.0123	CbGeAlD
Glycine—GLYATL2—bone marrow—acquired immunodeficiency syndrome	0.00555	0.0119	CbGeAlD
Glycine—SLC6A5—nervous system—acquired immunodeficiency syndrome	0.00547	0.0118	CbGeAlD
Glycine—SHMT1—blood plasma—acquired immunodeficiency syndrome	0.0054	0.0116	CbGeAlD
Glycine—SLC6A5—central nervous system—acquired immunodeficiency syndrome	0.00527	0.0113	CbGeAlD
Glycine—Lung disorder—Ritonavir—acquired immunodeficiency syndrome	0.00526	0.0138	CcSEcCtD
Glycine—SLC32A1—spinal cord—acquired immunodeficiency syndrome	0.0051	0.011	CbGeAlD
Glycine—Cardiovascular disorder—Indinavir—acquired immunodeficiency syndrome	0.00506	0.0133	CcSEcCtD
Glycine—Lung disorder—Saquinavir—acquired immunodeficiency syndrome	0.00506	0.0133	CcSEcCtD
Glycine—GATM—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00493	0.0317	CbGpPWpGaD
Glycine—SLC6A9—spinal cord—acquired immunodeficiency syndrome	0.00492	0.0106	CbGeAlD
Glycine—ALAS2—blood—acquired immunodeficiency syndrome	0.00481	0.0103	CbGeAlD
Glycine—GPR18—lymphoid tissue—acquired immunodeficiency syndrome	0.00472	0.0102	CbGeAlD
Glycine—GLYATL2—nervous system—acquired immunodeficiency syndrome	0.00465	0.01	CbGeAlD
Glycine—ALAS2—bone marrow—acquired immunodeficiency syndrome	0.00465	0.01	CbGeAlD
Glycine—GLYATL2—central nervous system—acquired immunodeficiency syndrome	0.00448	0.00964	CbGeAlD
Glycine—GRIN3B—lung—acquired immunodeficiency syndrome	0.00448	0.00964	CbGeAlD
Glycine—GPR18—blood—acquired immunodeficiency syndrome	0.00445	0.00956	CbGeAlD
Glycine—GPR18—bone marrow—acquired immunodeficiency syndrome	0.0043	0.00925	CbGeAlD
Glycine—SLC32A1—nervous system—acquired immunodeficiency syndrome	0.0043	0.00924	CbGeAlD
Glycine—Cardiovascular disorder—Ritonavir—acquired immunodeficiency syndrome	0.00423	0.0112	CcSEcCtD
Glycine—ALAS2—lung—acquired immunodeficiency syndrome	0.00421	0.00906	CbGeAlD
Glycine—AGXT—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00419	0.027	CbGpPWpGaD
Glycine—SLC6A5—brain—acquired immunodeficiency syndrome	0.00418	0.009	CbGeAlD
Glycine—GLRA3—nervous system—acquired immunodeficiency syndrome	0.00415	0.00892	CbGeAlD
Glycine—SLC6A9—nervous system—acquired immunodeficiency syndrome	0.00415	0.00892	CbGeAlD
Glycine—SLC32A1—central nervous system—acquired immunodeficiency syndrome	0.00414	0.0089	CbGeAlD
Glycine—GPR18—vagina—acquired immunodeficiency syndrome	0.00412	0.00887	CbGeAlD
Glycine—GCAT—skin of body—acquired immunodeficiency syndrome	0.0041	0.00883	CbGeAlD
Glycine—Cardiovascular disorder—Saquinavir—acquired immunodeficiency syndrome	0.00408	0.0107	CcSEcCtD
Glycine—GSS—blood plasma—acquired immunodeficiency syndrome	0.00405	0.00872	CbGeAlD
Glycine—SLC6A9—central nervous system—acquired immunodeficiency syndrome	0.00399	0.00859	CbGeAlD
Glycine—GLRA3—central nervous system—acquired immunodeficiency syndrome	0.00399	0.00859	CbGeAlD
Glycine—Polyuria—Zidovudine—acquired immunodeficiency syndrome	0.00396	0.0104	CcSEcCtD
Glycine—Salivary hypersecretion—Delavirdine—acquired immunodeficiency syndrome	0.00391	0.0103	CcSEcCtD
Glycine—GPR18—lung—acquired immunodeficiency syndrome	0.0039	0.00838	CbGeAlD
Glycine—SHMT2—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.0038	0.0245	CbGpPWpGaD
Glycine—Lightheadedness—Efavirenz—acquired immunodeficiency syndrome	0.00376	0.00991	CcSEcCtD
Glycine—GARS—retina—acquired immunodeficiency syndrome	0.00373	0.00803	CbGeAlD
Glycine—Dehydration—Nelfinavir—acquired immunodeficiency syndrome	0.00373	0.00982	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00368	0.0237	CbGpPWpGaD
Glycine—GCSH—lung—acquired immunodeficiency syndrome	0.00365	0.00786	CbGeAlD
Glycine—GNMT—blood—acquired immunodeficiency syndrome	0.00364	0.00783	CbGeAlD
Glycine—AGXT2—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.00356	0.0229	CbGpPWpGaD
Glycine—GLYATL2—brain—acquired immunodeficiency syndrome	0.00356	0.00765	CbGeAlD
Glycine—GLRA1—nervous system—acquired immunodeficiency syndrome	0.00353	0.00759	CbGeAlD
Glycine—Thrombophlebitis—Efavirenz—acquired immunodeficiency syndrome	0.00353	0.00929	CcSEcCtD
Glycine—Polyuria—Efavirenz—acquired immunodeficiency syndrome	0.00348	0.00916	CcSEcCtD
Glycine—GLDC—blood—acquired immunodeficiency syndrome	0.00345	0.00743	CbGeAlD
Glycine—Coma—Ritonavir—acquired immunodeficiency syndrome	0.0034	0.00895	CcSEcCtD
Glycine—GLRA1—central nervous system—acquired immunodeficiency syndrome	0.0034	0.00731	CbGeAlD
Glycine—GCSH—nervous system—acquired immunodeficiency syndrome	0.00338	0.00728	CbGeAlD
Glycine—GLDC—spinal cord—acquired immunodeficiency syndrome	0.00333	0.00715	CbGeAlD
Glycine—Polyuria—Delavirdine—acquired immunodeficiency syndrome	0.00333	0.00876	CcSEcCtD
Glycine—SLC32A1—brain—acquired immunodeficiency syndrome	0.00328	0.00706	CbGeAlD
Glycine—GARS—skin of body—acquired immunodeficiency syndrome	0.00328	0.00705	CbGeAlD
Glycine—GCSH—central nervous system—acquired immunodeficiency syndrome	0.00326	0.007	CbGeAlD
Glycine—SHMT2—retina—acquired immunodeficiency syndrome	0.00325	0.00698	CbGeAlD
Glycine—PIPOX—blood—acquired immunodeficiency syndrome	0.00322	0.00693	CbGeAlD
Glycine—Lightheadedness—Saquinavir—acquired immunodeficiency syndrome	0.0032	0.00844	CcSEcCtD
Glycine—GLDC—vagina—acquired immunodeficiency syndrome	0.0032	0.00688	CbGeAlD
Glycine—SLC6A9—brain—acquired immunodeficiency syndrome	0.00317	0.00682	CbGeAlD
Glycine—GLRA3—brain—acquired immunodeficiency syndrome	0.00317	0.00682	CbGeAlD
Glycine—GCAT—blood—acquired immunodeficiency syndrome	0.00313	0.00672	CbGeAlD
Glycine—PIPOX—spinal cord—acquired immunodeficiency syndrome	0.0031	0.00668	CbGeAlD
Glycine—BAAT—Bile acid and bile salt metabolism—ALB—acquired immunodeficiency syndrome	0.00308	0.0198	CbGpPWpGaD
Glycine—Polyuria—Ritonavir—acquired immunodeficiency syndrome	0.00308	0.0081	CcSEcCtD
Glycine—Thirst—Delavirdine—acquired immunodeficiency syndrome	0.00307	0.00808	CcSEcCtD
Glycine—SLC6A9—lymph node—acquired immunodeficiency syndrome	0.00306	0.00659	CbGeAlD
Glycine—GLDC—lung—acquired immunodeficiency syndrome	0.00303	0.00651	CbGeAlD
Glycine—GCAT—bone marrow—acquired immunodeficiency syndrome	0.00303	0.00651	CbGeAlD
Glycine—GCAT—spinal cord—acquired immunodeficiency syndrome	0.00301	0.00648	CbGeAlD
Glycine—Thrombophlebitis—Saquinavir—acquired immunodeficiency syndrome	0.003	0.00791	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.003	0.0193	CbGpPWpGaD
Glycine—PIPOX—vagina—acquired immunodeficiency syndrome	0.00299	0.00643	CbGeAlD
Glycine—Hyponatraemia—Delavirdine—acquired immunodeficiency syndrome	0.00293	0.00772	CcSEcCtD
Glycine—SHMT1—Amino acid and derivative metabolism—TAT—acquired immunodeficiency syndrome	0.0029	0.0187	CbGpPWpGaD
Glycine—GCAT—vagina—acquired immunodeficiency syndrome	0.0029	0.00623	CbGeAlD
Glycine—ALAS1—digestive system—acquired immunodeficiency syndrome	0.00288	0.00619	CbGeAlD
Glycine—GLRA2—nervous system—acquired immunodeficiency syndrome	0.00288	0.00619	CbGeAlD
Glycine—Chills—Didanosine—acquired immunodeficiency syndrome	0.00286	0.00753	CcSEcCtD
Glycine—SHMT2—skin of body—acquired immunodeficiency syndrome	0.00285	0.00613	CbGeAlD
Glycine—Thirst—Ritonavir—acquired immunodeficiency syndrome	0.00284	0.00747	CcSEcCtD
Glycine—PIPOX—lung—acquired immunodeficiency syndrome	0.00283	0.00608	CbGeAlD
Glycine—Polyuria—Lamivudine—acquired immunodeficiency syndrome	0.00282	0.00744	CcSEcCtD
Glycine—GLDC—nervous system—acquired immunodeficiency syndrome	0.0028	0.00603	CbGeAlD
Glycine—GPR18—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.0028	0.018	CbGpPWpGaD
Glycine—Rhinitis—Nelfinavir—acquired immunodeficiency syndrome	0.00278	0.00732	CcSEcCtD
Glycine—Rhinitis—Stavudine—acquired immunodeficiency syndrome	0.00277	0.0073	CcSEcCtD
Glycine—GLRA2—central nervous system—acquired immunodeficiency syndrome	0.00277	0.00596	CbGeAlD
Glycine—Visual disturbance—Saquinavir—acquired immunodeficiency syndrome	0.00274	0.00723	CcSEcCtD
Glycine—GCAT—lung—acquired immunodeficiency syndrome	0.00274	0.0059	CbGeAlD
Glycine—ALAS1—blood—acquired immunodeficiency syndrome	0.00274	0.00589	CbGeAlD
Glycine—Thirst—Saquinavir—acquired immunodeficiency syndrome	0.00273	0.00719	CcSEcCtD
Glycine—Angina pectoris—Indinavir—acquired immunodeficiency syndrome	0.00272	0.00716	CcSEcCtD
Glycine—GLDC—central nervous system—acquired immunodeficiency syndrome	0.0027	0.0058	CbGeAlD
Glycine—GPR18—lymph node—acquired immunodeficiency syndrome	0.00267	0.00573	CbGeAlD
Glycine—GARS—lymphoid tissue—acquired immunodeficiency syndrome	0.00265	0.00571	CbGeAlD
Glycine—ALAS1—bone marrow—acquired immunodeficiency syndrome	0.00265	0.0057	CbGeAlD
Glycine—ALAS1—spinal cord—acquired immunodeficiency syndrome	0.00264	0.00568	CbGeAlD
Glycine—GARS—digestive system—acquired immunodeficiency syndrome	0.00262	0.00564	CbGeAlD
Glycine—PIPOX—nervous system—acquired immunodeficiency syndrome	0.00262	0.00563	CbGeAlD
Glycine—Hyponatraemia—Saquinavir—acquired immunodeficiency syndrome	0.00261	0.00687	CcSEcCtD
Glycine—Thirst—Lamivudine—acquired immunodeficiency syndrome	0.00261	0.00686	CcSEcCtD
Glycine—GCSH—brain—acquired immunodeficiency syndrome	0.00259	0.00556	CbGeAlD
Glycine—Urinary retention—Ritonavir—acquired immunodeficiency syndrome	0.00257	0.00676	CcSEcCtD
Glycine—ALAS1—vagina—acquired immunodeficiency syndrome	0.00254	0.00546	CbGeAlD
Glycine—GCAT—nervous system—acquired immunodeficiency syndrome	0.00254	0.00546	CbGeAlD
Glycine—PIPOX—central nervous system—acquired immunodeficiency syndrome	0.00252	0.00542	CbGeAlD
Glycine—Dehydration—Ritonavir—acquired immunodeficiency syndrome	0.00251	0.00662	CcSEcCtD
Glycine—GCSH—lymph node—acquired immunodeficiency syndrome	0.0025	0.00537	CbGeAlD
Glycine—GARS—blood—acquired immunodeficiency syndrome	0.0025	0.00537	CbGeAlD
Glycine—GATM—digestive system—acquired immunodeficiency syndrome	0.00249	0.00535	CbGeAlD
Glycine—Chills—Stavudine—acquired immunodeficiency syndrome	0.00248	0.00653	CcSEcCtD
Glycine—Chills—Abacavir—acquired immunodeficiency syndrome	0.00244	0.00644	CcSEcCtD
Glycine—GCAT—central nervous system—acquired immunodeficiency syndrome	0.00244	0.00526	CbGeAlD
Glycine—SHMT2—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00244	0.0157	CbGpPWpGaD
Glycine—Dehydration—Saquinavir—acquired immunodeficiency syndrome	0.00242	0.00637	CcSEcCtD
Glycine—GARS—bone marrow—acquired immunodeficiency syndrome	0.00241	0.00519	CbGeAlD
Glycine—Rhinitis—Zidovudine—acquired immunodeficiency syndrome	0.00241	0.00635	CcSEcCtD
Glycine—GARS—spinal cord—acquired immunodeficiency syndrome	0.0024	0.00517	CbGeAlD
Glycine—ALAS1—lung—acquired immunodeficiency syndrome	0.0024	0.00517	CbGeAlD
Glycine—Back pain—Nelfinavir—acquired immunodeficiency syndrome	0.00234	0.00615	CcSEcCtD
Glycine—Back pain—Stavudine—acquired immunodeficiency syndrome	0.00233	0.00613	CcSEcCtD
Glycine—GARS—vagina—acquired immunodeficiency syndrome	0.00231	0.00498	CbGeAlD
Glycine—SHMT2—lymphoid tissue—acquired immunodeficiency syndrome	0.00231	0.00496	CbGeAlD
Glycine—Dehydration—Lamivudine—acquired immunodeficiency syndrome	0.00231	0.00607	CcSEcCtD
Glycine—GATM—spinal cord—acquired immunodeficiency syndrome	0.00228	0.00491	CbGeAlD
Glycine—SHMT2—digestive system—acquired immunodeficiency syndrome	0.00228	0.0049	CbGeAlD
Glycine—ALAS1—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.00226	0.0145	CbGpPWpGaD
Glycine—GNMT—brain—acquired immunodeficiency syndrome	0.00226	0.00486	CbGeAlD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00223	0.0143	CbGpPWpGaD
Glycine—SHMT2—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.00223	0.0143	CbGpPWpGaD
Glycine—ALAS1—nervous system—acquired immunodeficiency syndrome	0.00222	0.00479	CbGeAlD
Glycine—GSS—retina—acquired immunodeficiency syndrome	0.00222	0.00477	CbGeAlD
Glycine—GLRA2—brain—acquired immunodeficiency syndrome	0.0022	0.00473	CbGeAlD
Glycine—GATM—vagina—acquired immunodeficiency syndrome	0.0022	0.00472	CbGeAlD
Glycine—GARS—lung—acquired immunodeficiency syndrome	0.00219	0.00471	CbGeAlD
Glycine—SHMT2—blood—acquired immunodeficiency syndrome	0.00217	0.00467	CbGeAlD
Glycine—Chills—Zidovudine—acquired immunodeficiency syndrome	0.00216	0.00568	CcSEcCtD
Glycine—GPR18—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00216	0.0139	CbGpPWpGaD
Glycine—GLDC—brain—acquired immunodeficiency syndrome	0.00214	0.00461	CbGeAlD
Glycine—ALAS1—central nervous system—acquired immunodeficiency syndrome	0.00214	0.00461	CbGeAlD
Glycine—Vertigo—Abacavir—acquired immunodeficiency syndrome	0.00213	0.00561	CcSEcCtD
Glycine—Rhinitis—Efavirenz—acquired immunodeficiency syndrome	0.00212	0.00558	CcSEcCtD
Glycine—SHMT2—bone marrow—acquired immunodeficiency syndrome	0.0021	0.00452	CbGeAlD
Glycine—SHMT1—lymphoid tissue—acquired immunodeficiency syndrome	0.0021	0.00452	CbGeAlD
Glycine—Convulsion—Nelfinavir—acquired immunodeficiency syndrome	0.00209	0.00551	CcSEcCtD
Glycine—GATM—lung—acquired immunodeficiency syndrome	0.00208	0.00447	CbGeAlD
Glycine—SHMT1—digestive system—acquired immunodeficiency syndrome	0.00207	0.00446	CbGeAlD
Glycine—GLDC—lymph node—acquired immunodeficiency syndrome	0.00207	0.00445	CbGeAlD
Glycine—Convulsion—Abacavir—acquired immunodeficiency syndrome	0.00205	0.00541	CcSEcCtD
Glycine—Visual impairment—Efavirenz—acquired immunodeficiency syndrome	0.00203	0.00536	CcSEcCtD
Glycine—Oedema—Nevirapine—acquired immunodeficiency syndrome	0.00203	0.00536	CcSEcCtD
Glycine—GARS—nervous system—acquired immunodeficiency syndrome	0.00203	0.00436	CbGeAlD
Glycine—Rhinitis—Delavirdine—acquired immunodeficiency syndrome	0.00203	0.00534	CcSEcCtD
Glycine—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.00202	0.00533	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00202	0.013	CbGpPWpGaD
Glycine—SHMT2—vagina—acquired immunodeficiency syndrome	0.00201	0.00433	CbGeAlD
Glycine—Chills—Indinavir—acquired immunodeficiency syndrome	0.00201	0.00528	CcSEcCtD
Glycine—PIPOX—brain—acquired immunodeficiency syndrome	0.002	0.0043	CbGeAlD
Glycine—GRIN2C—nervous system—acquired immunodeficiency syndrome	0.00199	0.00429	CbGeAlD
Glycine—SHMT2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00199	0.0128	CbGpPWpGaD
Glycine—SHMT1—blood—acquired immunodeficiency syndrome	0.00198	0.00425	CbGeAlD
Glycine—Oedema—Nelfinavir—acquired immunodeficiency syndrome	0.00197	0.00519	CcSEcCtD
Glycine—GLRB—spinal cord—acquired immunodeficiency syndrome	0.00196	0.00422	CbGeAlD
Glycine—GARS—central nervous system—acquired immunodeficiency syndrome	0.00195	0.0042	CbGeAlD
Glycine—GSS—skin of body—acquired immunodeficiency syndrome	0.00195	0.00419	CbGeAlD
Glycine—GCAT—brain—acquired immunodeficiency syndrome	0.00194	0.00417	CbGeAlD
Glycine—Oedema—Abacavir—acquired immunodeficiency syndrome	0.00193	0.0051	CcSEcCtD
Glycine—Pain—Didanosine—acquired immunodeficiency syndrome	0.00193	0.0051	CcSEcCtD
Glycine—GATM—nervous system—acquired immunodeficiency syndrome	0.00192	0.00414	CbGeAlD
Glycine—GRIN2C—central nervous system—acquired immunodeficiency syndrome	0.00192	0.00413	CbGeAlD
Glycine—SHMT1—bone marrow—acquired immunodeficiency syndrome	0.00191	0.00411	CbGeAlD
Glycine—SHMT2—lung—acquired immunodeficiency syndrome	0.0019	0.00409	CbGeAlD
Glycine—GLRB—vagina—acquired immunodeficiency syndrome	0.00189	0.00406	CbGeAlD
Glycine—Back pain—Indinavir—acquired immunodeficiency syndrome	0.00188	0.00496	CcSEcCtD
Glycine—Vertigo—Zidovudine—acquired immunodeficiency syndrome	0.00188	0.00495	CcSEcCtD
Glycine—GCAT—lymph node—acquired immunodeficiency syndrome	0.00187	0.00403	CbGeAlD
Glycine—Rhinitis—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00493	CcSEcCtD
Glycine—GATM—central nervous system—acquired immunodeficiency syndrome	0.00185	0.00398	CbGeAlD
Glycine—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.00183	0.00483	CcSEcCtD
Glycine—SHMT1—vagina—acquired immunodeficiency syndrome	0.00183	0.00394	CbGeAlD
Glycine—Chills—Delavirdine—acquired immunodeficiency syndrome	0.00181	0.00477	CcSEcCtD
Glycine—Convulsion—Zidovudine—acquired immunodeficiency syndrome	0.00181	0.00477	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00181	0.0117	CbGpPWpGaD
Glycine—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.00181	0.00476	CcSEcCtD
Glycine—Rhinitis—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.00475	CcSEcCtD
Glycine—Visual impairment—Ritonavir—acquired immunodeficiency syndrome	0.0018	0.00474	CcSEcCtD
Glycine—GLRB—lung—acquired immunodeficiency syndrome	0.00178	0.00384	CbGeAlD
Glycine—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.00178	0.00468	CcSEcCtD
Glycine—SLC36A1—digestive system—acquired immunodeficiency syndrome	0.00177	0.00381	CbGeAlD
Glycine—SHMT1—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00177	0.0114	CbGpPWpGaD
Glycine—SHMT2—nervous system—acquired immunodeficiency syndrome	0.00176	0.00379	CbGeAlD
Glycine—Vertigo—Indinavir—acquired immunodeficiency syndrome	0.00175	0.0046	CcSEcCtD
Glycine—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00174	0.00458	CcSEcCtD
Glycine—Visual impairment—Saquinavir—acquired immunodeficiency syndrome	0.00173	0.00456	CcSEcCtD
Glycine—SHMT1—lung—acquired immunodeficiency syndrome	0.00173	0.00373	CbGeAlD
Glycine—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.00456	CcSEcCtD
Glycine—Rhinitis—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00453	CcSEcCtD
Glycine—Oedema—Zidovudine—acquired immunodeficiency syndrome	0.00171	0.0045	CcSEcCtD
Glycine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.0017	0.00448	CcSEcCtD
Glycine—ALAS1—brain—acquired immunodeficiency syndrome	0.0017	0.00366	CbGeAlD
Glycine—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0017	0.00447	CcSEcCtD
Glycine—SHMT2—central nervous system—acquired immunodeficiency syndrome	0.0017	0.00365	CbGeAlD
Glycine—GPR18—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.0017	0.0109	CbGpPWpGaD
Glycine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00168	0.00444	CcSEcCtD
Glycine—Pain—Stavudine—acquired immunodeficiency syndrome	0.00168	0.00442	CcSEcCtD
Glycine—Chills—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00442	CcSEcCtD
Glycine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00167	0.00439	CcSEcCtD
Glycine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.00437	CcSEcCtD
Glycine—Pain—Abacavir—acquired immunodeficiency syndrome	0.00165	0.00436	CcSEcCtD
Glycine—GLRB—nervous system—acquired immunodeficiency syndrome	0.00165	0.00355	CbGeAlD
Glycine—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.00165	0.00435	CcSEcCtD
Glycine—BAAT—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00165	0.0106	CbGpPWpGaD
Glycine—ALAS1—lymph node—acquired immunodeficiency syndrome	0.00164	0.00353	CbGeAlD
Glycine—GRIN2A—spinal cord—acquired immunodeficiency syndrome	0.00163	0.00352	CbGeAlD
Glycine—SLC36A1—bone marrow—acquired immunodeficiency syndrome	0.00163	0.00351	CbGeAlD
Glycine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.00162	0.00426	CcSEcCtD
Glycine—Chills—Saquinavir—acquired immunodeficiency syndrome	0.00161	0.00425	CcSEcCtD
Glycine—SHMT2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.00161	0.0104	CbGpPWpGaD
Glycine—SHMT1—nervous system—acquired immunodeficiency syndrome	0.0016	0.00345	CbGeAlD
Glycine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00159	0.0042	CcSEcCtD
Glycine—GLRB—central nervous system—acquired immunodeficiency syndrome	0.00159	0.00342	CbGeAlD
Glycine—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00159	0.00418	CcSEcCtD
Glycine—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.00158	0.00416	CcSEcCtD
Glycine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00158	0.00416	CcSEcCtD
Glycine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00157	0.00414	CcSEcCtD
Glycine—GRIN2A—vagina—acquired immunodeficiency syndrome	0.00157	0.00338	CbGeAlD
Glycine—GPR18—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00157	0.0101	CbGpPWpGaD
Glycine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00157	0.00412	CcSEcCtD
Glycine—SLC36A1—vagina—acquired immunodeficiency syndrome	0.00156	0.00336	CbGeAlD
Glycine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00156	0.00411	CcSEcCtD
Glycine—GSS—digestive system—acquired immunodeficiency syndrome	0.00156	0.00335	CbGeAlD
Glycine—GARS—brain—acquired immunodeficiency syndrome	0.00155	0.00333	CbGeAlD
Glycine—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00155	0.00408	CcSEcCtD
Glycine—SHMT1—central nervous system—acquired immunodeficiency syndrome	0.00154	0.00332	CbGeAlD
Glycine—Chills—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00405	CcSEcCtD
Glycine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00154	0.00405	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00153	0.00987	CbGpPWpGaD
Glycine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00404	CcSEcCtD
Glycine—GRIN2C—brain—acquired immunodeficiency syndrome	0.00152	0.00328	CbGeAlD
Glycine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.00151	0.00399	CcSEcCtD
Glycine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.0015	0.00395	CcSEcCtD
Glycine—GARS—lymph node—acquired immunodeficiency syndrome	0.0015	0.00322	CbGeAlD
Glycine—GSS—blood—acquired immunodeficiency syndrome	0.00148	0.00319	CbGeAlD
Glycine—SLC36A1—lung—acquired immunodeficiency syndrome	0.00148	0.00318	CbGeAlD
Glycine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00147	0.00388	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00147	0.00947	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00147	0.00947	CbGpPWpGaD
Glycine—GATM—brain—acquired immunodeficiency syndrome	0.00147	0.00316	CbGeAlD
Glycine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.00146	0.00386	CcSEcCtD
Glycine—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.00146	0.00385	CcSEcCtD
Glycine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00146	0.00385	CcSEcCtD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00145	0.00934	CbGpPWpGaD
Glycine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00145	0.00382	CcSEcCtD
Glycine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00145	0.00381	CcSEcCtD
Glycine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.00144	0.0038	CcSEcCtD
Glycine—SHMT2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.00144	0.00927	CbGpPWpGaD
Glycine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00144	0.00379	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00144	0.00924	CbGpPWpGaD
Glycine—GSS—bone marrow—acquired immunodeficiency syndrome	0.00144	0.00309	CbGeAlD
Glycine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00378	CcSEcCtD
Glycine—GSS—spinal cord—acquired immunodeficiency syndrome	0.00143	0.00308	CbGeAlD
Glycine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00143	0.00376	CcSEcCtD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00142	0.00915	CbGpPWpGaD
Glycine—GATM—lymph node—acquired immunodeficiency syndrome	0.00142	0.00306	CbGeAlD
Glycine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00141	0.00371	CcSEcCtD
Glycine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.00141	0.0037	CcSEcCtD
Glycine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.0014	0.00369	CcSEcCtD
Glycine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00139	0.00367	CcSEcCtD
Glycine—GRIN2A—nervous system—acquired immunodeficiency syndrome	0.00138	0.00296	CbGeAlD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00138	0.00885	CbGpPWpGaD
Glycine—GSS—vagina—acquired immunodeficiency syndrome	0.00138	0.00296	CbGeAlD
Glycine—SLC36A1—nervous system—acquired immunodeficiency syndrome	0.00137	0.00294	CbGeAlD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.00137	0.00879	CbGpPWpGaD
Glycine—Pain—Indinavir—acquired immunodeficiency syndrome	0.00136	0.00358	CcSEcCtD
Glycine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00136	0.00357	CcSEcCtD
Glycine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00136	0.00357	CcSEcCtD
Glycine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00135	0.00355	CcSEcCtD
Glycine—SHMT2—brain—acquired immunodeficiency syndrome	0.00135	0.0029	CbGeAlD
Glycine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00134	0.00354	CcSEcCtD
Glycine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00134	0.00354	CcSEcCtD
Glycine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.00353	CcSEcCtD
Glycine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00134	0.00353	CcSEcCtD
Glycine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.0035	CcSEcCtD
Glycine—GRIN2A—central nervous system—acquired immunodeficiency syndrome	0.00133	0.00285	CbGeAlD
Glycine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00132	0.00349	CcSEcCtD
Glycine—SLC36A1—central nervous system—acquired immunodeficiency syndrome	0.00132	0.00283	CbGeAlD
Glycine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.0013	0.00343	CcSEcCtD
Glycine—SHMT2—lymph node—acquired immunodeficiency syndrome	0.0013	0.0028	CbGeAlD
Glycine—GSS—lung—acquired immunodeficiency syndrome	0.0013	0.0028	CbGeAlD
Glycine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.0013	0.00342	CcSEcCtD
Glycine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.0013	0.00341	CcSEcCtD
Glycine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00341	CcSEcCtD
Glycine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00129	0.00341	CcSEcCtD
Glycine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00128	0.00338	CcSEcCtD
Glycine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00128	0.00337	CcSEcCtD
Glycine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00337	CcSEcCtD
Glycine—GLRB—brain—acquired immunodeficiency syndrome	0.00126	0.00272	CbGeAlD
Glycine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00126	0.00332	CcSEcCtD
Glycine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00125	0.0033	CcSEcCtD
Glycine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00125	0.00329	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00124	0.00801	CbGpPWpGaD
Glycine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00327	CcSEcCtD
Glycine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00123	0.00324	CcSEcCtD
Glycine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00123	0.00323	CcSEcCtD
Glycine—SHMT1—brain—acquired immunodeficiency syndrome	0.00123	0.00264	CbGeAlD
Glycine—GLRB—lymph node—acquired immunodeficiency syndrome	0.00122	0.00262	CbGeAlD
Glycine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00122	0.00321	CcSEcCtD
Glycine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00121	0.00318	CcSEcCtD
Glycine—GSS—nervous system—acquired immunodeficiency syndrome	0.0012	0.00259	CbGeAlD
Glycine—ALAS2—Metabolism—TAT—acquired immunodeficiency syndrome	0.00119	0.00768	CbGpPWpGaD
Glycine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00314	CcSEcCtD
Glycine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.00119	0.00314	CcSEcCtD
Glycine—SHMT1—lymph node—acquired immunodeficiency syndrome	0.00119	0.00255	CbGeAlD
Glycine—SHMT2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.00117	0.00754	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00117	0.00753	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00117	0.00753	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00117	0.00753	CbGpPWpGaD
Glycine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00117	0.00308	CcSEcCtD
Glycine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00308	CcSEcCtD
Glycine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00117	0.00308	CcSEcCtD
Glycine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00117	0.00307	CcSEcCtD
Glycine—SHMT2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.00116	0.00748	CbGpPWpGaD
Glycine—GSS—central nervous system—acquired immunodeficiency syndrome	0.00116	0.0025	CbGeAlD
Glycine—SLC16A10—lymphoid tissue—acquired immunodeficiency syndrome	0.00116	0.00248	CbGeAlD
Glycine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00115	0.00303	CcSEcCtD
Glycine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00114	0.003	CcSEcCtD
Glycine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.003	CcSEcCtD
Glycine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00114	0.00299	CcSEcCtD
Glycine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00113	0.00297	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.00112	0.0072	CbGpPWpGaD
Glycine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00291	CcSEcCtD
Glycine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00109	0.00288	CcSEcCtD
Glycine—SLC16A10—blood—acquired immunodeficiency syndrome	0.00109	0.00234	CbGeAlD
Glycine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00109	0.00286	CcSEcCtD
Glycine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00109	0.00286	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00107	0.00687	CbGpPWpGaD
Glycine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00279	CcSEcCtD
Glycine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.00278	CcSEcCtD
Glycine—GRIN2A—brain—acquired immunodeficiency syndrome	0.00105	0.00226	CbGeAlD
Glycine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00105	0.00277	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00105	0.00674	CbGpPWpGaD
Glycine—SLC36A1—brain—acquired immunodeficiency syndrome	0.00105	0.00225	CbGeAlD
Glycine—GARS—Gene Expression—CCNT1—acquired immunodeficiency syndrome	0.00104	0.00671	CbGpPWpGaD
Glycine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00104	0.00275	CcSEcCtD
Glycine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00103	0.0027	CcSEcCtD
Glycine—ALAS2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00102	0.00653	CbGpPWpGaD
Glycine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00101	0.00267	CcSEcCtD
Glycine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00101	0.00267	CcSEcCtD
Glycine—SLC36A1—lymph node—acquired immunodeficiency syndrome	0.00101	0.00217	CbGeAlD
Glycine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00101	0.00266	CcSEcCtD
Glycine—GPR18—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.00101	0.00649	CbGpPWpGaD
Glycine—SLC16A10—vagina—acquired immunodeficiency syndrome	0.00101	0.00217	CbGeAlD
Glycine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000992	0.00261	CcSEcCtD
Glycine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000982	0.00259	CcSEcCtD
Glycine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000978	0.00258	CcSEcCtD
Glycine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000968	0.00255	CcSEcCtD
Glycine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000954	0.00251	CcSEcCtD
Glycine—SLC16A10—lung—acquired immunodeficiency syndrome	0.000953	0.00205	CbGeAlD
Glycine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000949	0.0025	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000949	0.0061	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000948	0.0061	CbGpPWpGaD
Glycine—SHMT2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000946	0.00609	CbGpPWpGaD
Glycine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000943	0.00248	CcSEcCtD
Glycine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.00248	CcSEcCtD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000936	0.00602	CbGpPWpGaD
Glycine—GSS—brain—acquired immunodeficiency syndrome	0.000921	0.00198	CbGeAlD
Glycine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000913	0.0024	CcSEcCtD
Glycine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000908	0.00239	CcSEcCtD
Glycine—GLYAT—Metabolism—TAT—acquired immunodeficiency syndrome	0.000905	0.00582	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000905	0.00582	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000905	0.00582	CbGpPWpGaD
Glycine—GATM—Metabolism—TAT—acquired immunodeficiency syndrome	0.000905	0.00582	CbGpPWpGaD
Glycine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000898	0.00237	CcSEcCtD
Glycine—GPR18—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000891	0.00573	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000891	0.00573	CbGpPWpGaD
Glycine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000891	0.00235	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00089	0.00573	CbGpPWpGaD
Glycine—GSS—lymph node—acquired immunodeficiency syndrome	0.00089	0.00191	CbGeAlD
Glycine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000878	0.00231	CcSEcCtD
Glycine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000874	0.0023	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000871	0.0056	CbGpPWpGaD
Glycine—BAAT—Metabolism—TAT—acquired immunodeficiency syndrome	0.000863	0.00555	CbGpPWpGaD
Glycine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000853	0.00225	CcSEcCtD
Glycine—GPR18—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000849	0.00546	CbGpPWpGaD
Glycine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000845	0.00223	CcSEcCtD
Glycine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000844	0.00222	CcSEcCtD
Glycine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000834	0.0022	CcSEcCtD
Glycine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000812	0.00214	CcSEcCtD
Glycine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000806	0.00212	CcSEcCtD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000802	0.00516	CbGpPWpGaD
Glycine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000788	0.00208	CcSEcCtD
Glycine—GPR18—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000787	0.00506	CbGpPWpGaD
Glycine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000775	0.00204	CcSEcCtD
Glycine—GATM—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00077	0.00495	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00077	0.00495	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00077	0.00495	CbGpPWpGaD
Glycine—AGXT—Metabolism—TAT—acquired immunodeficiency syndrome	0.00077	0.00495	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00077	0.00495	CbGpPWpGaD
Glycine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000759	0.002	CcSEcCtD
Glycine—ALAS1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000745	0.00479	CbGpPWpGaD
Glycine—SLC6A9—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000744	0.00478	CbGpPWpGaD
Glycine—SLC6A5—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000744	0.00478	CbGpPWpGaD
Glycine—BAAT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000734	0.00472	CbGpPWpGaD
Glycine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000724	0.00191	CcSEcCtD
Glycine—SHMT1—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000691	0.00445	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000678	0.00436	CbGpPWpGaD
Glycine—AGXT2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000654	0.00421	CbGpPWpGaD
Glycine—AGXT—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000654	0.00421	CbGpPWpGaD
Glycine—SLC16A10—lymph node—acquired immunodeficiency syndrome	0.000652	0.0014	CbGeAlD
Glycine—ALAS1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000634	0.00408	CbGpPWpGaD
Glycine—SLC32A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000633	0.00407	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000611	0.00393	CbGpPWpGaD
Glycine—SHMT1—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000558	0.00359	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000556	0.00358	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000538	0.00346	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000536	0.00345	CbGpPWpGaD
Glycine—SHMT1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000533	0.00343	CbGpPWpGaD
Glycine—GSS—Metabolism—TAT—acquired immunodeficiency syndrome	0.00052	0.00334	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000514	0.00331	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000514	0.00331	CbGpPWpGaD
Glycine—SHMT1—Disease—APOBEC3G—acquired immunodeficiency syndrome	0.000509	0.00327	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000504	0.00324	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000504	0.00324	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000487	0.00313	CbGpPWpGaD
Glycine—GRIN2C—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.00047	0.00302	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000465	0.00299	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000457	0.00294	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000457	0.00294	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000454	0.00292	CbGpPWpGaD
Glycine—GSS—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000442	0.00284	CbGpPWpGaD
Glycine—SHMT1—Disease—CCNT1—acquired immunodeficiency syndrome	0.000433	0.00278	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000383	0.00246	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000378	0.00243	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000378	0.00243	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000377	0.00243	CbGpPWpGaD
Glycine—SLC36A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000363	0.00234	CbGpPWpGaD
Glycine—GRIN2A—Alzheimers Disease—TNF—acquired immunodeficiency syndrome	0.000359	0.00231	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000348	0.00224	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000345	0.00222	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000343	0.0022	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000338	0.00217	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000321	0.00207	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000321	0.00207	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000321	0.00207	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000318	0.00204	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000314	0.00202	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000292	0.00188	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000287	0.00185	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.00027	0.00174	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.00027	0.00174	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000262	0.00169	CbGpPWpGaD
Glycine—SHMT1—Disease—CXCR4—acquired immunodeficiency syndrome	0.000227	0.00146	CbGpPWpGaD
Glycine—SLC16A10—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000221	0.00142	CbGpPWpGaD
Glycine—ALAS2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000208	0.00134	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000207	0.00133	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000206	0.00132	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000202	0.0013	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000199	0.00128	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000185	0.00119	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000185	0.00119	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000181	0.00116	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—acquired immunodeficiency syndrome	0.000158	0.00101	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—acquired immunodeficiency syndrome	0.000158	0.00101	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—acquired immunodeficiency syndrome	0.000158	0.00101	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000158	0.00101	CbGpPWpGaD
Glycine—SHMT1—Disease—CCR5—acquired immunodeficiency syndrome	0.000156	0.001	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—acquired immunodeficiency syndrome	0.000151	0.000968	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—acquired immunodeficiency syndrome	0.000134	0.000863	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—acquired immunodeficiency syndrome	0.00013	0.000836	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000114	0.000734	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	0.000112	0.000722	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000107	0.000688	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000106	0.000685	CbGpPWpGaD
Glycine—SHMT1—Disease—CD4—acquired immunodeficiency syndrome	9.79e-05	0.000629	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—acquired immunodeficiency syndrome	9.3e-05	0.000598	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—acquired immunodeficiency syndrome	9.06e-05	0.000583	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.29e-05	0.000404	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—acquired immunodeficiency syndrome	5.29e-05	0.00034	CbGpPWpGaD
